Three cases of jaundice after ingestion of 3,4-methylenedioxymetamphetamine (MDMA), known as 'ecstasy', are reported and the complications associated with the misuse of this drug, which was initially misrepresented as 'safer than alcohol' are described. Ingestion of 'ecstasy' should be considered when investigating unexplained jaundice in younger patients. (Gut 1995; 36: 939-941) 
Case 1
A 24 year old male insulin dependent diabetic car mechanic was admitted with progressive, painless jaundice.
While 'out' with friends three days before admission, he became unwell with agitation, nausea, and profuse sweating. It Haematoxylin and eosin, original magnification X 1600.
contained a dense infiltrate of inflammatory cells, predominantly lymphocytes, but with frequent plasma cells and eosinophils (Fig 2) . In some areas there was evidence of 'spillover' of inflammatory cells into the periphery of lobules. The patient's liver function tests continued to improve without specific treatment and were normal five weeks after hospital admission. Serological tests remained negative for hepatitis B and C six months after the illness.
Discussion
The synthesis of MDMA None of our patients gave a history of heavy alcohol intake or of intravenous drug misuse and, although the clinical presentation would have been compatible, none had evidence of viral hepatitis. The interval between ingestion of the drug and the initial symptoms varied; from three days (in case one) to four weeks (in case two). Pruritis was present in two of the patients.
The degree of hepatic dysfunction in the patients reported in published works was severe in most cases and lead to death in one patient and to liver transplantation in another. 4 The peak bilirubin concentrations in our patients varied from 75 ,umol/l to 371 pumol/l and the peak aspartate aminotransferase from 639 to 1410 U/1 in case three and two respectively (Table) . Liver biopsy, where performed (Shearman et al, 8 Gorard et al 9 and case three in this report), showed evidence of acute hepatitis with lobular disarray and centrilobular drop out of hepatocytes. Recovery from the hepatic insult takes place over a variable amount of time, from three weeks to three months.
Hepatotoxicity should be recognised as a clear complication of MDMA misuse and the increasing number of cases reported, makes it worth exploring 'ecstasy' as an aetiological agent when investigating young people presenting with painless jaundice.
